Health Care Reform, Efficiency of Health Insurers, and Optimal Health Insurance Markets

2014 ◽  
Vol 18 (4) ◽  
pp. 478-500 ◽  
Author(s):  
Charles C. Yang
Author(s):  
Daniel M. Hausman

Evaluating health care institutions and policies should depend on understanding the economic complexities of health care provision and on our values of compassion, choice, efficiency, fairness, and solidarity. These values may conflict, so applying them is difficult. We must also understand the problems with health care allocation, including employing markets. Regulations are needed first because of asymmetric information: doctors know more about treatments than patients and can exploit them. Second, health insurance is a better bargain for those who expect to be sick. Consequently, health insurance policies attract purchasers more likely to make claims. This adverse selection makes claims and premiums skyrocket, healthy people drop out, and private health insurance markets collapse, unless everyone is forced to buy insurance or insurers deny insurance to those with pre-existing conditions. Third is moral hazard: if insurance pays for a health problem, there is less incentive to avoid it or to economize on treating it. Health care policies must be economically sound and morally defensible.


2007 ◽  
Vol 2 (2) ◽  
pp. 173-192 ◽  
Author(s):  
FRANCESCO PAOLUCCI ◽  
ERIK SCHUT ◽  
KONSTANTIN BECK ◽  
STEFAN GREß ◽  
CARINE VAN DE VOORDE ◽  
...  

Abstract:As the share of supplementary health insurance (SI) in health care finance is likely to grow, SI may become an increasingly attractive tool for risk-selection in basic health insurance (BI). In this paper, we develop a conceptual framework to assess the probability that insurers will use SI for favourable risk-selection in BI. We apply our framework to five countries in which risk-selection via SI is feasible: Belgium, Germany, Israel, the Netherlands, and Switzerland. For each country, we review the available evidence of SI being used as selection device. We find that the probability that SI is and will be used for risk-selection substantially varies across countries. Finally, we discuss several strategies for policy makers to reduce the chance that SI will be used for risk-selection in BI markets.


2004 ◽  
Vol 23 (4) ◽  
pp. 167-175 ◽  
Author(s):  
Alan C. Monheit ◽  
Joel C. Cantor ◽  
Margaret Koller ◽  
Kimberley S. Fox

Diabetes Care ◽  
1994 ◽  
Vol 17 (6) ◽  
pp. 611-613 ◽  
Author(s):  
W. H. Herman ◽  
E. J. Dasbach

Sign in / Sign up

Export Citation Format

Share Document